Cancer Management and Research

期刊全称Cancer Management and Research
期刊缩写CANCER MANAG RES
涉及主题
(科研通AI识别)
医学生物遗传学内科学癌症病理化学生物化学肿瘤科外科癌症研究基因数学免疫学统计细胞凋亡放射科
期刊介绍

Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include: ◦Epidemiology, detection and screening ◦Cellular research and biomarkers ◦Identification of biotargets and agents with novel mechanisms of action ◦Optimal clinical use of existing anticancer agents, including combination therapies ◦Radiation and surgery ◦Palliative care ◦Patient adherence, quality of life, satisfaction The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.

期刊ISSNprint: 1179-1322
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
2.53.33.6023.9892.8862.2433.7023.851
历年发表/被引量
(科研通AI通过大数据分析)
年份20252024202320222021202020192018201720162015201420132012
发表量941641533308931262928678911731434347
被引量489612481139551548413676908143301539964850820708428299
h-Index32
自引率0.00%
涉及的研究领域Medicine-Oncology
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 肿瘤学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ3181/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ3205/326
期刊主页https://www.dovepress.com/cancer-management-and-research-journal
投稿网址https://www.dovepress.com/submit_step_1.php
出版商Dove Medical Press Ltd.
出版国家(地区)UNITED STATES
出版语言English
每年出版文章数814
Gold OA文章占比96.28%
原创研究文献占比
(排除综述)
77.30%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

Directory of Open Access Journals (DOAJ)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322%5BISSN%5D
平均审稿周期16 Weeks
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈